首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi 再生醫學分子標靶治療學細胞療法基因療法

市場調查報告書

商品編碼

1378743

分子細胞遺傳學市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Molecular Cytogenetics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年11月02日 | 出版商:

IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

概要

2022年全球分子細胞遺傳學市場規模達到24億美元。展望未來， IMARC Group預計到2028年市場規模將達到44億美元，2022-2028年複合年成長率（CAGR）為10.6%。

分子細胞遺傳學是指透過脫氧核糖核酸 (DNA) 機制研究基因突變和疾病的生物醫學研究。它研究染色體及其細胞核的結構和功能組織、基因組變異、表達、進化和異常，特別是在醫學和癌症相關遺傳學方面。 DNA 擴增、DNA 分離、基因篩選、虛擬核型分析和螢光原位雜合技術 (FISH) 等技術通常用於分子細胞遺傳學，透過使用 DNA 探針來視覺化和標記基因組或其目標區域。這些技術對於各種惡性腫瘤和血液系統惡性腫瘤的診斷和治療非常有益。

癌症和其他遺傳性疾病盛行率的增加以及老年人口的增加是推動市場成長的關鍵因素之一。分子細胞遺傳學主要用於開發疾病特徵的預測模型和有效的治療策略。此外，癌症治療標靶療法的廣泛採用也促進了市場的成長。 FISH 和比較基因組雜交 (CGH) 也用於藥物基因組生物標記研究，以分析癌症進展階段並為患者提供個人化治療。此外，各種技術進步，例如改進的消耗品、試劑、軟體和套件的開發，也是其他成長誘導因素。這些進步有助於產生可重複、準確且可靠的臨床病理測試結果。其他因素，包括醫療保健基礎設施的顯著改善，以及生物醫學領域的廣泛研發（R＆D）活動，預計將進一步推動市場發展。

本報告回答的關鍵問題

2022年全球分子細胞遺傳學市場規模有多大？
2023-2028年全球分子細胞遺傳學市場的預期成長率是多少？
COVID-19 對全球分子細胞遺傳學市場有何影響？
推動全球分子細胞遺傳學市場的關鍵因素是什麼？
根據產品類型，全球分子細胞遺傳學市場的詳細情形如何？
基於該技術的全球分子細胞遺傳學市場的詳細情形如何？
全球分子細胞遺傳學市場基於應用的詳細情形如何？
基於最終用戶的全球分子細胞遺傳學市場的細分是什麼？
全球分子細胞遺傳學市場的關鍵區域有哪些？
全球分子細胞遺傳學市場的主要參與者/公司有哪些？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太地區
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 按國家/地區分類的市場細分
- 市場預測

第 11 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 14 章：價格分析

第15章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Abbott Laboratories
- Agilent Technologies Inc.
- Applied Spectral Imaging Inc.
- Biological Industries
- Bio-RAD Laboratories Inc.
- BioView Inc.
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Illumina Inc.
- Oxford Gene Technology
- Perkinelmer Inc.
- Quest Diagnostics Incorporated

簡介目錄圖表

Product Code: SR112023A2623

Abstract

The global molecular cytogenetics market size reached US$ 2.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2028, exhibiting a growth rate (CAGR) of 10.6% during 2022-2028.

Molecular cytogenetics refers to the biomedical research of deoxyribonucleic acid (DNA) mechanisms to investigate genetic mutations and disorders. It studies the structural and functional organization of the chromosomes and their nucleus, genomic variations, expression, evolution and abnormalities, especially in medicinal and cancer-related genetics. Techniques such as DNA amplification, DNA isolation, gene screens, virtual karyotyping and fluorescence in situ hybridization (FISH) are commonly used for molecular cytogenetics by using DNA probes to visualize and label the genome or its targeted regions. These techniques are highly beneficial in the diagnosis and treatment of various malignant tumors and hematological malignancies.

The increasing prevalence of cancer and other genetic disorders, along with the rising geriatric population, is one of the key factors driving the growth of the market. Molecular cytogenetics is primarily being used for developing predictive models of disease traits and effective treatment strategies. Furthermore, the widespread adoption of targeted therapies for cancer treatment is also augmenting the market growth. FISH and Comparative Genomic Hybridization (CGH) are also used for pharmacogenomic biomarker studies to analyze cancer progression stages and provide personalized treatment to the patient. Additionally, various technological advancements, such as the development of improved consumables, reagents, software and kits, are acting as other growth-inducing factors. These advancements aid in generating duplicatable, accurate and reliable clinical-pathological test results. Other factors, including significant improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biomedical sciences, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global molecular cytogenetics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, technology, application and end user.

Breakup by Product Type:

Instruments

Consumables

Software and Services

Others

Breakup by Technology:

Comparative Genomic Hybridization

Fluorescence in SITU Hybridization (FISH)

Immunohistochemistry

Karyotyping

Others

Breakup by Application:

Genetic Disorders

Oncology

Personalized Medicine

Others

Breakup by End User:

Clinical and Research Laboratories

Hospitals and Pathology Laboratories

Pharmaceutical and Biotechnology Companies

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies Inc., Applied Spectral Imaging Inc., Biological Industries, Bio-RAD Laboratories Inc., BioView Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Illumina Inc., Oxford Gene Technology, Perkinelmer Inc. and Quest Diagnostics Incorporated.

Key Questions Answered in This Report

1. What was the size of the global molecular cytogenetics market in 2022?
2. What is the expected growth rate of the global molecular cytogenetics market during 2023-2028?
3. What has been the impact of COVID-19 on the global molecular cytogenetics market?
4. What are the key factors driving the global molecular cytogenetics market?
5. What is the breakup of the global molecular cytogenetics market based on the product type?
6. What is the breakup of the global molecular cytogenetics market based on the technology?
7. What is the breakup of the global molecular cytogenetics market based on application?
8. What is the breakup of the global molecular cytogenetics market based on the end user?
9. What are the key regions in the global molecular cytogenetics market?
10. Who are the key players/companies in the global molecular cytogenetics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Molecular Cytogenetics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type

6.1 Instruments
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Consumables
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Software and Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast

7 Market Breakup by Technology

7.1 Comparative Genomic Hybridization
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Fluorescence in SITU Hybridization (FISH)
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Immunohistochemistry
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Karyotyping
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by Application

8.1 Genetic Disorders
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Oncology
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Personalized Medicine
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by End User

9.1 Clinical and Research Laboratories
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Hospitals and Pathology Laboratories
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Pharmaceutical and Biotechnology Companies
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Agilent Technologies Inc.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 Applied Spectral Imaging Inc.
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
- 15.3.4 Biological Industries
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
- 15.3.5 Bio-RAD Laboratories Inc.
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 BioView Inc.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
- 15.3.7 Danaher Corporation
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 F. Hoffmann-La Roche AG
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 SWOT Analysis
- 15.3.9 Illumina Inc.
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Oxford Gene Technology
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
- 15.3.11 Perkinelmer Inc.
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis
- 15.3.12 Quest Diagnostics Incorporated
  - 15.3.12.1 Company Overview
  - 15.3.12.2 Product Portfolio
  - 15.3.12.3 Financials

簡介目錄圖表

List of Figures

Figure 1: Global: Molecular Cytogenetics Market: Major Drivers and Challenges
Figure 2: Global: Molecular Cytogenetics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Molecular Cytogenetics Market: Breakup by Product Type (in %), 2022
Figure 4: Global: Molecular Cytogenetics Market: Breakup by Technology (in %), 2022
Figure 5: Global: Molecular Cytogenetics Market: Breakup by Application (in %), 2022
Figure 6: Global: Molecular Cytogenetics Market: Breakup by End User (in %), 2022
Figure 7: Global: Molecular Cytogenetics Market: Breakup by Region (in %), 2022
Figure 8: Global: Molecular Cytogenetics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 9: Global: Molecular Cytogenetics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Molecular Cytogenetics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Molecular Cytogenetics (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Molecular Cytogenetics (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Molecular Cytogenetics (Software and Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Molecular Cytogenetics (Software and Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Molecular Cytogenetics (Other Product Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Molecular Cytogenetics (Other Product Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Molecular Cytogenetics (Comparative Genomic Hybridization) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Molecular Cytogenetics (Comparative Genomic Hybridization) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Molecular Cytogenetics (Fluorescence in SITU Hybridization - FISH) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Molecular Cytogenetics (Fluorescence in SITU Hybridization - FISH) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Molecular Cytogenetics (Immunohistochemistry) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Molecular Cytogenetics (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Molecular Cytogenetics (Karyotyping) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Molecular Cytogenetics (Karyotyping) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Molecular Cytogenetics (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Molecular Cytogenetics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Molecular Cytogenetics (Genetic Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Molecular Cytogenetics (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Molecular Cytogenetics (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Molecular Cytogenetics (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Molecular Cytogenetics (Personalized Medicine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Molecular Cytogenetics (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Molecular Cytogenetics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Molecular Cytogenetics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Molecular Cytogenetics (Clinical and Research Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Molecular Cytogenetics (Clinical and Research Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Molecular Cytogenetics (Hospitals and Pathology Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Molecular Cytogenetics (Hospitals and Pathology Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Molecular Cytogenetics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Molecular Cytogenetics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: Molecular Cytogenetics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: Molecular Cytogenetics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: North America: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: North America: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: United States: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: United States: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Canada: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Canada: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Asia Pacific: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Asia Pacific: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: China: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: China: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Japan: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Japan: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: India: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: India: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: South Korea: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: South Korea: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Australia: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Australia: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Indonesia: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Indonesia: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Others: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Europe: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Europe: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Germany: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Germany: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: France: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: France: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: United Kingdom: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: United Kingdom: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Italy: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Italy: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Spain: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Spain: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Russia: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Russia: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Others: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Latin America: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Latin America: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Brazil: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Brazil: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Mexico: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Mexico: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Others: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Middle East and Africa: Molecular Cytogenetics Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Middle East and Africa: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 91: Global: Molecular Cytogenetics Industry: SWOT Analysis
Figure 92: Global: Molecular Cytogenetics Industry: Value Chain Analysis
Figure 93: Global: Molecular Cytogenetics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Molecular Cytogenetics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Molecular Cytogenetics Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
Table 3: Global: Molecular Cytogenetics Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 4: Global: Molecular Cytogenetics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Molecular Cytogenetics Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Molecular Cytogenetics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Molecular Cytogenetics Market Structure
Table 8: Global: Molecular Cytogenetics Market: Key Players

02-2729-4219

+886-2-2729-4219